Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dowsett

Showing results (251-260 of 304) with videos related to

Pageof 31
Sort By:
Breast Cancer Research and Treatment|May 22, 1998
Reduced apoptosis and proliferation and increased Bcl-2 in residual breast cancer following preoperative chemotherapyP A Ellis, I E Smith, S Detre, et al.
British Journal of Cancer|January 1, 1997
Absence of p21 expression is associated with abnormal p53 in human breast carcinomasP A Ellis, P E Lonning, A Borresen-Dale, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 1999
Double-blind, randomised, multicentre endocrine trial comparing two letrozole doses, in postmenopausal breast cancer patientsE Bajetta, N Zilembo, M Dowsett, et al.
Lancet (London, England)|September 15, 1984
Low-dose aminoglutethimide in treatment of advanced breast cancerR Stuart-Harris, M Dowsett, T Bozek, et al.
Anticancer Research|April 22, 2011
Effect of tamoxifen or anastrozole on steroid sulfatase activity and serum androgen concentrations in postmenopausal women with breast cancerS J Stanway, C Palmieri, F Z Stanczyk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Impact of tamoxifen on the pharmacokinetics and endocrine effects of the aromatase inhibitor letrozole in postmenopausal women with breast cancerM Dowsett, C Pfister, S R Johnston, et al.
Breast Cancer Research and Treatment|April 29, 2008
A randomised study of the effects of letrozole and anastrozole on oestrogen receptor positive breast cancers in postmenopausal womenJ Murray, O E Young, L Renshaw, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 30, 2013
HER2 staining intensity in HER2-positive disease: relationship with FISH amplification and clinical outcome in the HERA trial of adjuvant trastuzumabL Zabaglo, O Stoss, J Rüschoff, et al.
British Journal of Cancer|December 1, 1994
Measurement of S-phase fraction and ploidy in sequential fine-needle aspirates from primary human breast tumours treated with tamoxifenI N Fernando, J C Titley, T J Powles, et al.
British Journal of Cancer|March 1, 1996
Comparison of MIB-1 proliferation index with S-phase fraction in human breast carcinomasP A Ellis, A Makris, S A Burton, et al.
Pageof 31

Showing results (251-260 of 304) with videos related to

Sort By:
Pageof 31
Breast Cancer Research and Treatment|May 22, 1998
Reduced apoptosis and proliferation and increased Bcl-2 in residual breast cancer following preoperative chemotherapyP A Ellis, I E Smith, S Detre, et al.
British Journal of Cancer|January 1, 1997
Absence of p21 expression is associated with abnormal p53 in human breast carcinomasP A Ellis, P E Lonning, A Borresen-Dale, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 1999
Double-blind, randomised, multicentre endocrine trial comparing two letrozole doses, in postmenopausal breast cancer patientsE Bajetta, N Zilembo, M Dowsett, et al.
Lancet (London, England)|September 15, 1984
Low-dose aminoglutethimide in treatment of advanced breast cancerR Stuart-Harris, M Dowsett, T Bozek, et al.
Anticancer Research|April 22, 2011
Effect of tamoxifen or anastrozole on steroid sulfatase activity and serum androgen concentrations in postmenopausal women with breast cancerS J Stanway, C Palmieri, F Z Stanczyk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Impact of tamoxifen on the pharmacokinetics and endocrine effects of the aromatase inhibitor letrozole in postmenopausal women with breast cancerM Dowsett, C Pfister, S R Johnston, et al.
Breast Cancer Research and Treatment|April 29, 2008
A randomised study of the effects of letrozole and anastrozole on oestrogen receptor positive breast cancers in postmenopausal womenJ Murray, O E Young, L Renshaw, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 30, 2013
HER2 staining intensity in HER2-positive disease: relationship with FISH amplification and clinical outcome in the HERA trial of adjuvant trastuzumabL Zabaglo, O Stoss, J Rüschoff, et al.
British Journal of Cancer|December 1, 1994
Measurement of S-phase fraction and ploidy in sequential fine-needle aspirates from primary human breast tumours treated with tamoxifenI N Fernando, J C Titley, T J Powles, et al.
British Journal of Cancer|March 1, 1996
Comparison of MIB-1 proliferation index with S-phase fraction in human breast carcinomasP A Ellis, A Makris, S A Burton, et al.
Pageof 31